Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antigen bronchial challenges: uses, misuses, and problems.

D G Tinkelman1

  • 1Department of Allergy, Medical College of Georgia, Atlanta.

Annals of Allergy
|November 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Barriers to measuring and achieving optimal outcomes in pediatric asthma.

The Journal of allergy and clinical immunology·2001
Same author

Disease management program improves asthma outcomes.

The American journal of managed care·2000
Same author

A multicenter, placebo-controlled study of twice daily triamcinolone acetonide (800 microg per day) for the treatment of patients with mild-to-moderate asthma.

The Journal of allergy and clinical immunology·1998
Same author

Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group.

The Journal of pediatrics·1998
Same author

The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis.

Allergy and asthma proceedings·1998
Same author

Proventil HFA provides bronchodilation comparable to ventolin over 12 weeks of regular use in asthmatics.

Chest·1998
Same journal

Hay fever; a review of the literature for 1945.

Annals of allergy·2010
Same journal

Nasal and sputum smears.

Annals of allergy·2010
Same journal

Determination of penicillin-susceptible strains of bacteria.

Annals of allergy·2010
Same journal

Fleabite reactions; clinical and experimental observations and effect of histamine-azoprotein therapy.

Annals of allergy·2010
Same journal

D.H.E. 45 (dihydroergotamine) in the treatment of allergic megraine.

Annals of allergy·2010
Same journal

Antigenicity of proteins in relation to allergy.

Annals of allergy·2010
See all related articles

Antigen bronchial challenge effectively assesses asthma treatments but has interpretation challenges and risks. Careful patient instruction is crucial for managing potential late-phase reactions during this asthma research method.

Area of Science:

  • Pulmonology
  • Allergy and Immunology
  • Clinical Research Methods

Background:

  • Asthma management relies on understanding disease mechanisms and treatment efficacy.
  • The antigen bronchial challenge (ABC) is a key research tool in asthma studies.
  • Clinical application of ABC is limited by interpretation difficulties and patient safety concerns.

Purpose of the Study:

  • To highlight the utility of antigen bronchial challenge in asthma research.
  • To discuss the limitations and practical challenges of implementing ABC in clinical settings.
  • To emphasize the importance of patient education for managing adverse reactions.

Main Methods:

  • Review of existing literature on antigen bronchial challenge in asthma.
  • Analysis of the benefits and drawbacks of ABC for evaluating asthma treatments.

Related Experiment Videos

  • Discussion of safety protocols and patient management during ABC procedures.

    • Main Results:

    • ABC is a valuable method for assessing new asthma therapies and basic disease understanding.
    • Interpretation of ABC results can be complex, limiting widespread clinical use.
    • Significant patient morbidity can occur, necessitating careful monitoring.

    Conclusions:

    • Antigen bronchial challenge remains an important research tool for asthma.
    • Clinical implementation requires addressing interpretation issues and potential risks.
    • Proper patient instruction, particularly regarding late-phase reactions, is essential for safe use.